Works by ERIKSSON, BARBRO


Results: 70
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy -- Biotherapy and Novel Targeted Agents.

    Published in:
    Neuroendocrinology, 2017, v. 105, n. 3, p. 266, doi. 10.1159/000471880
    By:
    • Pavel, Marianne;
    • Valle, Juan W.;
    • Eriksson, Barbro;
    • Rinke, anja;
    • Caplin, Martyn;
    • Chen, Jie;
    • Costa, Frederico;
    • Falkerby, Jenny;
    • Fazio, Nicola;
    • Gorbounova, Vera;
    • de Herder, Wouter;
    • Kulke, Matthew;
    • Lombard-Bohas, Catherine;
    • O'Connor, Juan;
    • Sorbye, Halfdan;
    • Garcia-Carbonero, Rocio
    Publication type:
    Article
    12

    ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging.

    Published in:
    Neuroendocrinology, 2017, v. 105, n. 3, p. 212, doi. 10.1159/000471879
    By:
    • Sundin, anders;
    • arnold, Rudolf;
    • Baudin, Eric;
    • Cwikla, Jaroslaw B.;
    • Eriksson, Barbro;
    • Fanti, Stefano;
    • Fazio, Nicola;
    • Giammarile, Francesco;
    • Hicks, Rodney J.;
    • Kjaer, andreas;
    • Krenning, Eric;
    • Kwekkeboom, Dik;
    • Lombard-Bohas, Catherine;
    • O'Connor, Juan M.;
    • O'Toole, Dermot;
    • Rockall, andrea;
    • Wiedenmann, Bertram;
    • Valle, Juan W.;
    • Vullierme, Marie-Pierre
    Publication type:
    Article
    13
    14
    15

    Improving the Diagnosis and Management of Neuroendocrine Tumors: Utilizing New Advances in Biomarker and Molecular Imaging Science.

    Published in:
    Neuroendocrinology, 2013, v. 98, n. 1, p. 16, doi. 10.1159/000348832
    By:
    • Giandomenico, Valeria;
    • Modlin, Irvin M.;
    • Pontén, Fredrik;
    • Nilsson, Mats;
    • Landegren, Ulf;
    • Bergqvist, Jonas;
    • Khan, Mohid S.;
    • Millar, Robert P.;
    • Långström, Bengt;
    • Borlak, Jürgen;
    • Eriksson, Barbro;
    • Nielsen, Bengt;
    • Baltzer, Lars;
    • Waterton, John C.;
    • ahlström, Håkan;
    • Öberg, Kjell
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22

    Rare Functioning Pancreatic Endocrine Tumors.

    Published in:
    Neuroendocrinology, 2006, v. 84, n. 3, p. 189, doi. 10.1159/000098011
    By:
    • O'Toole, Dermot;
    • Salazar, Ramon;
    • Falconi, Massimo;
    • Kaltsas, Gregory;
    • Couvelard, Anne;
    • De Herder, Wouter W.;
    • Hyrdel, Rudolf;
    • Nikou, George;
    • Krenning, Eric;
    • Vullierme, Marie-Pierre;
    • Caplin, Martin;
    • Jensen, Robert;
    • Eriksson, Barbro
    Publication type:
    Article
    23

    Well-Differentiated Pancreatic Tumor/Carcinoma: Insulinoma.

    Published in:
    Neuroendocrinology, 2006, v. 84, n. 3, p. 183, doi. 10.1159/000098010
    By:
    • De Herder, Wouter W.;
    • Niederle, Bruno;
    • Scoazec, Jean-Yves;
    • Pauwels, Stanislas;
    • Klöppel, Günter;
    • Falconi, Massimo;
    • Kwekkeboom, Dik J.;
    • Öberg, Kjel;
    • Eriksson, Barbro;
    • Wiedenmann, Bertram;
    • Rindi, Guido;
    • O'Toole, Dermot;
    • Ferone, Diego
    Publication type:
    Article
    24
    25

    Rapid and Sustained Relief from the Symptoms of Carcinoid Syndrome: Results from an Open 6-Month Study of the 28-Day Prolonged-Release Formulation of Lanreotide.

    Published in:
    Neuroendocrinology, 2004, v. 80, n. 4, p. 244, doi. 10.1159/000082875
    By:
    • Ruszniewski, Philippe;
    • Ish-Shalom, Sofia;
    • Wymenga, Machteld;
    • O'Toole, Dermot;
    • Arnold, Rudolf;
    • Tomassetti, Paola;
    • Bax, Nigel;
    • Caplin, Martyn;
    • Eriksson, Barbro;
    • Glaser, Benjamin;
    • Ducreux, Michel;
    • Lombard-Bohas, Catherine;
    • De Herder, Wouter W.;
    • Delle Fave, Gianfranco;
    • Reed, Nick;
    • Seitz, Jean François;
    • Cutsem, Eric Van;
    • Grossman, Ashley;
    • Rougier, Philippe;
    • Schmidt, Wolfgang
    Publication type:
    Article
    26
    27
    28
    29
    30

    Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues.

    Published in:
    Drug Design, Development & Therapy, 2015, v. 9, p. 5075, doi. 10.2147/DDDT.S84177
    By:
    • Wolin, Edward M.;
    • Jarzab, Barbara;
    • Eriksson, Barbro;
    • Walter, Thomas;
    • Toumpanakis, Christos;
    • Morse, Michael A.;
    • Tomassetti, Paola;
    • Weber, Matthias M.;
    • Fogelman, David R.;
    • Ramage, John;
    • Poon, Donald;
    • Gadbaw, Brian;
    • Jiang Li;
    • Pasieka, Janice L.;
    • Mahamat, Abakar;
    • Swahn, Fredrik;
    • Newell-Price, John;
    • Mansoor, Wasat;
    • Öberg, Kjell
    Publication type:
    Article
    31
    32
    33
    34

    Prospective observational study of <sup>177</sup>Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 6, p. 970, doi. 10.1007/s00259-018-3945-z
    By:
    • Garske-Román, Ulrike;
    • Sandström, Mattias;
    • Fröss Baron, Katarzyna;
    • Lundin, Lars;
    • Hellman, Per;
    • Welin, Staffan;
    • Johansson, Silvia;
    • Khan, Tanweera;
    • Lundqvist, Hans;
    • Eriksson, Barbro;
    • Sundin, Anders;
    • Granberg, Dan
    Publication type:
    Article
    35

    Improved Localization of Insulinomas Using <sup>68</sup>Ga-NODAGA-Exendin-4 PET/CT.

    Published in:
    Journal of Nuclear Medicine, 2024, v. 65, n. 12, p. 1959, doi. 10.2967/jnumed.124.268158
    By:
    • Boss, Marti;
    • Eriksson, Olof;
    • Mikkola, Kirsi;
    • Eek, Annemarie;
    • Brom, Maarten;
    • Buitinga, Mijke;
    • Brouwers, Adrienne H.;
    • Velikyan, Irina;
    • Waser, Beatrice;
    • Kauhanen, Saila;
    • Solin, Olof;
    • Marciniak, Camille;
    • Eriksson, Barbro;
    • Reubi, Jean-Claude;
    • Aveline, Cyrielle;
    • Wild, Damian;
    • Pattou, Francois;
    • Talbot, Jean-Noel;
    • Hofland, Johannes;
    • Sundin, Anders
    Publication type:
    Article
    36

    Malignant Gastric Ghrelinoma with Hyperghrelinemia.

    Published in:
    Journal of Clinical Endocrinology & Metabolism, 2004, v. 89, n. 8, p. 3739, doi. 10.1210/jc.2003-032118
    By:
    • TSOLAKIS, APOSTOLOS V.;
    • PORTELA-GOMES, GUIDA M.;
    • STRIDSBERG, MATS;
    • GRIMELIUS, LARS;
    • SUNDIN, ANDERS;
    • ERIKSSON, BARBRO K.;
    • OBERG, KJELL E.;
    • JANSON, EVA T.
    Publication type:
    Article
    37
    38

    [sup 11] C-metomidate PET imaging of adrenocortical cancer.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2003, v. 30, n. 3, p. 403, doi. 10.1007/s00259-002-1025-9
    By:
    • Khan, Tanweera S.;
    • Sundin, Anders;
    • Juhlin, Claes;
    • Långström, Bengt;
    • Bergström, Mats;
    • Eriksson, Barbro
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45

    Treatment of hormone-producing adrenocortical cancer with o,p'DDD and streptozocin.

    Published in:
    1987
    By:
    • Eriksson, Barbro;
    • Öberg, KJELL;
    • Curstedt, Thore;
    • Hemmingsson, Anders;
    • Johansson, Professor Henry;
    • Lindh, Erik;
    • Lindgren, Per-Gunnar;
    • Thuomas, Karl-ÅKe;
    • Wilander, Erik;
    • Åkerström, GÖRAN;
    • Eriksson, B;
    • Oberg, K;
    • Curstedt, T;
    • Hemmingsson, A;
    • Johansson, H;
    • Lindh, E;
    • Lindgren, P G;
    • Thuomas, K A;
    • Wilander, E;
    • Akerström, G
    Publication type:
    journal article
    46
    47
    48
    49
    50

    PET in the Diagnosis of Neuroendocrine Tumors.

    Published in:
    Annals of the New York Academy of Sciences, 2004, v. 1014, n. 1, p. 246, doi. 10.1196/annals.1294.027
    By:
    • SUNDIN, ANDERS;
    • ERIKSSON, BARBRO;
    • BERGSTRÖM, MATS;
    • LÅNGSTRÖM, BENGT;
    • ÖBERG, KJELL;
    • ÖRLEFORS, HÅKAN
    Publication type:
    Article